1. Home
  2. FPAY vs BBIO Comparison

FPAY vs BBIO Comparison

Compare FPAY & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPAY
  • BBIO
  • Stock Information
  • Founded
  • FPAY 2003
  • BBIO 2015
  • Country
  • FPAY United States
  • BBIO United States
  • Employees
  • FPAY N/A
  • BBIO N/A
  • Industry
  • FPAY Diversified Commercial Services
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPAY Consumer Discretionary
  • BBIO Health Care
  • Exchange
  • FPAY Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • FPAY 31.0M
  • BBIO 6.7B
  • IPO Year
  • FPAY N/A
  • BBIO 2019
  • Fundamental
  • Price
  • FPAY $1.37
  • BBIO $34.48
  • Analyst Decision
  • FPAY Strong Buy
  • BBIO Strong Buy
  • Analyst Count
  • FPAY 2
  • BBIO 12
  • Target Price
  • FPAY $3.25
  • BBIO $57.09
  • AVG Volume (30 Days)
  • FPAY 47.1K
  • BBIO 3.2M
  • Earning Date
  • FPAY 05-20-2025
  • BBIO 04-29-2025
  • Dividend Yield
  • FPAY N/A
  • BBIO N/A
  • EPS Growth
  • FPAY N/A
  • BBIO N/A
  • EPS
  • FPAY N/A
  • BBIO N/A
  • Revenue
  • FPAY $139,800,732.00
  • BBIO $127,415,000.00
  • Revenue This Year
  • FPAY $12.05
  • BBIO $13.67
  • Revenue Next Year
  • FPAY N/A
  • BBIO $118.02
  • P/E Ratio
  • FPAY N/A
  • BBIO N/A
  • Revenue Growth
  • FPAY 19.51
  • BBIO N/A
  • 52 Week Low
  • FPAY $0.97
  • BBIO $21.62
  • 52 Week High
  • FPAY $2.37
  • BBIO $39.47
  • Technical
  • Relative Strength Index (RSI)
  • FPAY 53.97
  • BBIO 49.67
  • Support Level
  • FPAY $1.30
  • BBIO $33.92
  • Resistance Level
  • FPAY $1.47
  • BBIO $39.16
  • Average True Range (ATR)
  • FPAY 0.08
  • BBIO 1.43
  • MACD
  • FPAY 0.01
  • BBIO -0.16
  • Stochastic Oscillator
  • FPAY 61.76
  • BBIO 31.05

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: